Biology of Kaposi's sarcoma-associated herpesvirus

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 3, 2005, Pages 2882-2891

  Bryan, Benjaman A ^a   Dyson, Ossie F ^a   McCubrey, James A ^a   Akula, Shaw M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Endocytosis; HHV 8; KSHV; Raf; Review; VEGF; Virus Entry

Indexed keywords

ALITRETINOIN; ANTHRACYCLINE; CIDOFOVIR; FOSCARNET; GAMMA INTERFERON; GANCICLOVIR; ONCOPROTEIN; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BIOLOGY; CRYOTHERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOMA; PATHOGENESIS; PREVALENCE; REVIEW; VIRUS IDENTIFICATION; VIRUS INFECTION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA ASSOCIATED HERPESVIRUS;

EID: 21344433920     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1744     Document Type: Review

References (114)

1. Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelmen, Y. Chang & P. S. Moore: Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV-8). Proc Natl Acad. Sci USA 93, 14862-14867 (1996)
2. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles & P. S. Moore: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869 (1994)
3. Ganem, D.: Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma. Curr Clin. Top Infect Dis 18, 237-251 (1998)
4. McGeoch, D. J., A. Dolan & A. C. Ralph: Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J Virol 74, 10401-10406 (2000)
5. Davison, A. J.: Evolution of the herpesviruses. Vet Microbiol 86, 69-88 (2002)
6. Minson, A.C., A. Davison, R. Eberle, R. C. Desrosiers, B. Fleckenstein, D. J. McGeoch, P. E. Pellett, B. Roizman & M. J. Studdert: Family Herpesviridae. In: Van Regenmortel, M. H. V., C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle & R. B. Wickner (Eds.), Virus Taxonomy. Academic Press, San Diego, pp. 203-225 (2000)
7. Verschuren, E. W., N. Jones & G. I. Evan: The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. J Gen Virol 85, 1347-1361 (2004)
8. McGeoch, D. J., D. Gatherer & A: Dolan:On phylogenetic relationships among major lineages of the Gammaherpesvirinae. J Gen Virol 86, 307-316 (2005)
9. Neipel, F., J. C. Albrecht & B. Fleckenstein: Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol 71, 4187-4192 (1997)
10. Sarid, R., A. Klepfish & A. Schattner: Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Mayo Clin Proc 77, 941-9 (2002)
11. Verma, S. C. & E. S. Robertson: Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett 222, 155-163 (2003)
12. Gallo, R. C.: The enigmas of Kaposi's sarcoma. Science 252, 1837-1839 (1998)
13. Whitman, A. G., K. E. Hamden, P. W. Ford, J. A. McCubrey & S. M. Akula: Role for Raf in the entry of viruses associated with AIDS (review). Int J Oncol 25, 469-480 (2004)
14. Hoffman, L. J., C. H. Bunker, P. E. Pellett, D. L. Trump, A. L. Patrick, S. C. Dollard, H. A. Keenan & F. J. Jenkins: Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis 189, 15-20 (2004)
15. Bobroski, L., A. U. Bagasra, D. Patel, P. Saikumari, M. Memoli, M. V. Abbey, C. Wood, C. Sosa & O. Bagasra: Localization of human herpesvirus type 8 (HHV-8) in the Kaposi's sarcoma tissues and the semen specimens of HIV-1 infected and uninfected individuals by utilizing in situ polymerase chain reaction. J Reprod Immunol 41, 149-160 (1998)
16. Diamond, C., S. J. Brodie, J. N. Krieger, M. L. Huang, D. M. Koelle, K. Diem, D. Muthui & L. Corey: Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma. J Virol 72, 6223-6227 (1998)
17. Iscovich, J., P. Boffetta, R. Winkelmann & P. Brennan: Classic Kaposi's sarcoma as a second primary neoplasm. Int J Cancer 80, 178-182 (1999)
18. Monini, P., M. R. Howard, P. Rimessi, L. de Lellis, T. F. Schulz & E. Cassai: Human herpesvirus DNA in prostate and semen from HIV-negative individuals in Italy. AIDS 11, 1530-1532 (1997)
19. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K & Boshoff C. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 96, 4546-4551 (1999)
20. Ablashi, D. V., L. G. Chatlynne, J. E. Whitman, Jr. & E. Cesarman: Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15, 439-464 (2002)
21. Di Alberti, L., A. Piattelli, L. Artese, G. Favia, S. Patel, N. Saunders, S. R. Porter, C. M. Scully, S. L. Ngui & C. G. Teo: Human herpesvirus 8 variants in sarcoid tissues. Lancet 350, 1655-1661 (1997)
22. Belec, L., A. S. Mohamed, E. Lechapt-Zalcman, F. J. Authier, F. Lange & R. K. Gherardi: Lack of HHV-8 DNA sequences in sarcoid tissues of French patients. Chest 114, 948-949 (1998)
23. Gazouli, M., J. Ikonomopoulos, R. Trigidou, M. Foteinou, C. Kittas & V. Gorgoulis: Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of greek patients with sarcoidosis. J Clin Microbiol 40, 3060-3063 (2002)
24. Lebbe, C., F. Agbalika, B. Flageul, C. Pellet, M. Rybojad, F. Cordoliani, D. Farge, M. D. Vignon-Pennamen, J. Sheldon, P. Morel, F. Calvo & Schulz TF: No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis. Br J Dermatol 141, 492-496 (1999)
25. Klussmann, J. P., M. Wagner, O. Guntinas-Lichius & A. Muller: Detection of HHV-8 sequences and antigens in a MALT lymphoma associated with Sjogren's syndrome. J Oral Pathol Med 32, 243-245 (2003)
26. Puxeddu, R., G. Parodo, F. Locci, I. Puxeddu, P. E. Manconi & C. Ferreli: Parotid mass as an early sign of Kaposi's sarcoma associated with human herpesvirus 8 infection. J Laryngol Otol 116, 470-473 (2002)
27. Castle, J. T. & L. D. Thompson: Kaposi sarcoma of major salivary gland origin: A clinicopathologic series of six cases. Cancer 88, 15-23 (2000)
28. Atula, T., R. Grenman, P. Klemi & S. Syrjanen: Human papillomavirus, Epstein-Barr virus, human herpesvirus 8 and human cytomegalovirus involvement in salivary gland tumours. Oral Oncol 34, 391-395 (1998)
29. Klussmann, J. P., A. Muller, M. Wagner, O. Guntinas-Lichius, M. Jungehuelsing, T. Sloots, D. V. Ablashi & G. R. Krueger: Human herpesvirus type 8 in salivary gland tumors. J Clin Virol 16, 239-246 (2000)
30. Cesarman, E., Y. Chang, P. S. Moore, J. W. Said & D. M. Knowles: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332, 1186-1191 (1995)
31. Soulier, J., L.Grollet, E. Oksenhendler, P. Cacoub, D. Cazals-Hatem, P. Babinet, d M. F. 'Agay , J. P. Clauvel, M. Raphael & L. Degos: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280 (1995)
32. Boshoff, C. & R. Weiss: AIDS-related malignancies. Nat Rev Cancer 2, 373-382 (2002)
33. Wang, H. W., M. W. Trotter, D. Lagos, D. Bourboulia, S Henderson, T. Makinen, S. Elliman, A. M. Flanagan, K. Alitalo & C. Boshoff: Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36, 687-693 (2004)
34. Direkze, S. & H. Laman: Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes. Int J Exp Pathol 85, 305-319 (2004)
35. Blasig, C., C. Zietz, B. Haar, F. Neipel, S. Esser, N. H. Brockmeyer, E. Tschachler, S. Colombini, B. Ensoli & M. Sturzl: Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 71, 7963-7968 (1997)
36. Sirianni, M. C., S. Uccini, A. Angeloni, A. Faggioni, F. Cottoni & B. Ensoli: Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma. Lancet 349, 255 (1997)
37. Morand, P., M. Buisson, H. Collandre, B. Chanzy, O. Genoulaz, M. J. Bourgeat, N. Pinel, P. Leclercq, D. Leroux & V. Marechal: Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient. Leuk Lymphoma 35, 379-387 (1999)
38. Antman, K. & Y. Chang: Kaposi's sarcoma. N Engl J Med 342, 1027-1038 (2000)
39. Ziegler, J. L., T. Simonart & R. Snoeck: Kaposi's sarcoma, oncogenic viruses, and iron. J Clin Virol 20,127-30 (2001)
40. Dourmishev, L. A., A. L. Dourmishev, D. Palmeri, R. A. Schwartz & D. M. Lukac: Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67, 175-212 (2003)
41. Goedert, J. J.: The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 27, 390-401 (2000)
42. Schwartz, R. A.: Kaposi's sarcoma: advances and perspectives. J Am Acad Dermatol 34, 804-814 (1996)
43. Hengge, U. R., T. Ruzicka, S. K. Tyring, M. Stuschke, M. Roggendorf, R. A. Schwartz & S. Seeber: Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1. Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect. Dis 2, 281-292 (2002)
44. Moosa, M. R.: Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. Qjm 98, 205-214 (2005)
45. Kempf, W., G. Cathomas, G. Burg & R. M. Trueb: Micronodular Kaposi's sarcoma - a new variant of classic-sporadic Kaposi's sarcoma. Dermatology 208, 255-258 (2004)
46. Schulz, T. F.: KSHV/HHV8-associated lymphoproliferations in the AIDS setting. Eur J Cancer 37, 1217-1226 (2001)
47. Geraminejad, P., O. Memar, I. Aronson, P. L. Rady, U. Hengge & S. K. Tyring: Kaposi's sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol 47, 641-655; quiz 656-648 (2002)
48. Malnati, M. S., L. Dagna, M. Ponzoni & P. Lusso: Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. Rev Clin Exp Hematol 7, 375-405 (2003)
49. Viejo-Borbolla, A. & T. F. Schulz: Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. AIDS Rev 5, 222-229 (2003)
50. Akula, S. M., F. Z. Wang, J. Vieira & B. Chandran: Human herpesvirus 8 interaction with target cells involves heparan sulfate. Virology 282, 245-255 (2001)
51. Blackbourn, D. J., E. Lennette, B. Klencke, A. Moses, B. Chandran, M Weinstein, R. G. Glogau, M. H. Witte, D. L. Way, T. Kutzkey, B. Herndier & J. A. Levy: The restricted cellular host range of human herpesvirus 8. AIDS 14, 1123-1133 (2000)
52. Flore, O., S. Rafii, , S. Ely, , J. J. O'Leary, E. M. Hyjek & E. Cesarman: Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394, 588-592 (1998)
53. Moses, A. V., K. N. Fish, R. Ruhl, P. P. Smith, J. G. Strussenberg, L. Zhu, B. Chandran & J. A. Nelson: Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol 73, 6892-6902 (1999)
54. Renne, R., D. Blackbourn, D. Whitby, J. Levy & D. Ganem: Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 72, 5182-5188 (1998)
55. Vieira, J., O. Hearn, L. E. Kimball, B. Chandran & L. Corey: Activation of KSHV (HHV-8) lytic replication by human cytomegalovirus. J Virol 75, 1378-1386 (2001)
56. Neipel, F. and B. Fleckenstein: The role of HHV-8 in Kaposi's sarcoma. Semin Cancer Biol 9, 151-164 (1999)
57. Wang, F.-Z., S. M. Akula, N. P. Pramod, L. Zeng & B. Chandran: Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75, 7517-7527 (2001)
58. Chandran, B., M. S. Smith, D. M. Koelle, L. Corey, R. Horvat & E. Goldstein: Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 243, 208-217 (1998)
59. Zhu, L., V. Puri & B. Chandran: Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies. Virology 262, 237-249 (1999)
60. Spear, P. G. & R. Longnecker: Herpesvirus entry: an update. J Virol 77, 10179-10185 (2003)
61. Pertel, P. E.: Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion. J Virol 76, 4390-4400 (2002)
62. Akula, S. M., N. P. Pramod, F. Z. Wang & B. Chandran: Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology 284, 235-249 (2001)
63. Naranatt, P. P., S. M. Akula & B. Chandran: Characterization of 2-human herpesvirus-8 glycoproteins gH and gL. Arch Virol 147, 1349-1370 (2002)
64. Luna, R. E., F. Zhou, A. Baghian, V. Chouljenko, B. Forghani, S. J. Gao & K. G. Kousoulas: Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry. J Virol 78, 6389-6398 (2004)
65. Birkmann, A., A. Mahr, A. Ensser, S. Yaguboglu, F. Titgemeyer, B. Fleckenstein & F. Neipel: Cell surface heparan sulfate is a receptor forhuman herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol 75, 11583-11593 (2001)
66. Akula, S. M., N. P. Pramod, F. Z. Wang & B. Chandran: Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108, 407-419 (2002)
67. Akula, S. M., N. P. Pramod, N. S. Walia, F. Z. Wang, B. Fegley & B. Chandran: Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occur through endocytosis. J Virol 77, 7978-7990 (2003)
68. Wang, F. Z., S. M. Akula, N. S. Walia, L. Zeng & B. Chandran: Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence. J Virol 77, 3131-3147 (2003)
69. Meng, Y.X., T. J. Spira, G. J. Bhat, C. J. Birch, J. D. Druce, B. R. Edlin, R. Edwards, C. Gunthel, R. Newton, F. R. Stamey, C. Wood & P. E. Pellett: Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology 261, 106-19 (1999)
70. Spear, P. G.: Entry of alphaherpesviruses into cells. Semin Virol 4, 167-180 (1993)
71. Inoue, N, J. Winter, R. B. Lal, M. K. Offermann & S. Koyano: Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line. J Virol 77, 8147-8152 (2003)
72. Cocchi, F., L. Menotti, , V. Di Ninni, M. Lopez & G. Campadelli-Fiume: The herpes simplex virus JMP mutant enters receptor-negative J cells through a novel pathway independent of the known receptors nectin1, HveA, and nectin2. J Virol 78, 4720-4729 (2004)
73. Nicola, A. V., A. M. McEvoy & S. E. Straus: Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol 77, 5324-5332 (2003)
74. Cudmore, S., I. Reckmann & M. Way: Viral manipulations of the actin cytoskeleton. Trends Microbiol 5, 142-148 (1997)
75. Li, E., D. Stupack, G. M. Bokoch & G. R. Nemerow: Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J Virol 72, 8806-8812 (1998)
76. Naranatt, P. P., H. H. Krishnan, M. S. Smith & B. Chandran: Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus. J Virol 79, 1191-1206 (2005)
77. Spandidos, D. A., A. Kaloterakis, M. Yiagnisis, A. Varatsos & J. K. Field: Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma. Anticancer Res 10, 1619-1625 (1990)
78. Nicolaides, A., Y. Q. Huang, J. J. Li, W. G. Zhang & A. E. Friedman-Kien: Gene amplification and multiple mutations of the K-ras oncogene in Kaposi's sarcoma. Anticancer Res 14, 921-926 (1994)
79. Akula, S. M., P. W. Ford, A. G. Whitman, K. E. Hamden, B. A. Bryan, P. P. Cook & J. A. McCubrey: B-Raf dependent expression of vascular endothelial growth factor-A in Kaposi's sarcoma-associated herpesvirus infected human B cells. Blood (In Press) (2005)
80. Hamden, K. E., A. G. Whitman, P. W. Ford, Shelton, J. G., J. A. McCubrey & S. M. Akula: Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors. Leukemia 19, 18-26 (2005)
81. Faris, M., B Ensoli, N. Stahl, G. Yancopoulos, A. Nguyen, S. Wang & A. E. Nel: Differential activation of the extracellular signal-regulated kinase, Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells. Aids 10, 369-378 (1996)
82. Akula, S. M., P. W. Ford, A. G. Whitman, K. E. Hamden, J. G. Shelton & J. A. McCubrey: Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection. Oncogene 23, 5227-5241 (2004)
83. Ford, P. W., K. E. Hamden, A. G. Whitman, J. A. McCubrey & S. M. Akula: Vascular Endothelial Growth Factor Augments Human Herpesvirus-8 (HHV-8/KSHV) Infection. Cancer Biol Ther 3, 876-81 (2004)
84. Hamden, K. E., P. W. Ford, A. G. Whitman, O. F. Dyson, S. Y. Cheng, J. A. McCubrey & S. M. Akula: Raf-induced vascular endothelial growth factor augments Kaposi's sarcoma-associated herpesvirus infection. J Virol 78, 13381-13390 (2004)
85. Li, M, Lee H, J. Guo, F. Neipel, B. Fleckenstein, K. Ozato & J. U. Jung: Kaposi's sarcoma-associated Herpesvirus viral interferon regulatory factor. J Virol 72, 5433-5440 (1998)
86. Chiou, C. J., L. J. Poole, P. S. Kim, D. M. Ciufo, J. S. Cannon, C. M. ap Rhys, D. J. Alcendor, J. C. Zong, R. F. Ambinder & G. S. Hayward: Patterns of gene expression a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 76, 3421-3439 (2002)
87. Lagunoff, M., D. M. Lukac & D. Ganem: Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J Virol 75, 5891-5898 (2001)
88. Muralidhar, S., G. Veytsmann, B. Chandran, D. Ablashi, J. Doniger & L. J. Rosenthal: Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J Clin Virol 16, 203-213 (2000)
89. Sadler R., L. Wu, B. Forghani, R. Renne, W. Zhong, B. Herndier & D. Ganem: A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated Herpesvirus. J Virol 7, 5722-5730 (1999)
90. Curreli F., F. Cerimele, S. Muralidhar, L. J. Rosenthal, E. Cesarman, A. E. Friedman-Kien & O. Flore: Transcriptional Downregulation of ORF50/Rta by Methotrexate Inhibits the Switch of Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 from Latency to Lytic Replication. J Virol 76, 5208-5219 (2002)
91. Mebrahtu, S, U. Eriksson, U. Rauch, J. Warenholt, N. Bendsoe & M. Dictor: Effects of Kaposi's sarcoma-associated Herpesvirus ORF K1 on differentiating endothelium in murine embryoid bodies and teratomas. Exp Cell Res 292, 322-331 (2004)
92. Gao, S. J., C. Boshoff, S. Jayachandra, R. A. Weiss, Y. Chang & P. S. Moore: KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15, 1979-1985 (1997)
93. Bais, C., B. Santomasso, O. Coso, L. Arvanitakis, E.G. Raaka, J.S. Gutkind, A.S. Asch, E. Cesarman, M. C. Gerhengorn & E. A. Mesri: G-protein-coupled receptor of Kaposi's sarcoma-associated Herpesvirus is a viral oncogene and angiogenesis activator. Nature 391 (1998)
94. Cannon, M., N. J. Philpott & E. Cesarman: The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J Virol 77, 57-67 (2003)
95. Ensoli, B., M. Sturzl & P. Monini: Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Semin Cancer Biol 10, 367-381 (2000)
96. Ensoli, B. & M. Sturzl: Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9, 63-83 (1998)
97. Singh, V. K. & V. S. Yadav: Role of cytokines and growth factors in radioprotection. Exp Mol Pathol 78, 156-169 (2005)
98. Aoki, Y. & G. Tosato: Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood 94, 4247-4254 (1999)
99. Hayward, G. S.: Initiation of angiogenic Kaposi's sarcoma lesions. Cancer Cell 3, 1-3 (2003)
100. Masood, R., E. Cesarman, D.L. Smith, P. S. Gill & O. Flore: Human Herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Path 160, 23-29 (2002)
101. Nador, R. G., L. L. Milligan, O Flore, X Wang, L Arvanitakis, D. M. Knowles & E. Cesarman: Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas. Virology 287, 62-70 (2001)
102. Ferrara, N.: Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 9, 2-10 (2004)
103. Cross, M. J., J. Dixelius, T. Matsumoto & L. Claesson-Welsh: VEGF-receptor signal transduction. Trends Biochem Sci 28, 488-494 (2003)
104. Ruhrberg, C: Growing and shaping the vascular tree: multiple roles for VEGF. Bioessays 25, 1052-1060 (2003)
105. Bieker, R., T. Padro, J. Kramer, M. Steins, T. Kessler, S. Retzlaff, F. Herrera, J. Kienast, W. E. Berdel & R. M. Mesters: Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia. Cancer Res 63, 7241-726 (2003)
106. Cattelan, A. M., M. Trevenzoli & S. M. Aversa: Recent advances in the treatment of AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 3, 451-462 (2002)
107. Bartnof, H. S.: Kaposi's sarcoma. BETA 52, 14-21 (1996)
108. Harsch, I. A., H. G. Kraetsch, K. Amann, E. G. Hahn, J. H. Ficker & P. C. Konturek: Disseminated manifestation of Kaposi's Sarcoma in newly diagnosed AIDS in an African female. Med Sci Monit 7, 1303-1306 (2001)
109. Schwartz R. A.: Kaposi's sarcoma: an update. J Surg Oncol 87, 146-151 (2004)
110. Cheung, T. W.: AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive - the Trojan Horse is being destroyed" - Part A: Kaposi's sarcoma. Cancer Invest 22, 774-786 (2004)
111. Low, P., F. Neipel, A. Rascu, H. Steininger, B. Manger, B. Fleckenstein, J. R. Kalden & T. Harrer: Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome. Eur J Med Res 3, 461-464 (1998)
112. Sergerie, Y. & G. Boivin: Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR. J Clin Microbiol 41, 3897-3900 (2003)
113. Aversa, S. M., A. M. Cattelan, L. Salvagno, G. Crivellari, G. Banna, M. Trevenzoli, V. Chiarion-Sileni & S. Monfardini: Treatments of AIDS-related Kaposi's sarcoma. Crit Rev Oncol Hematol 53, 253-265 (2005)
114. Godfrey, A., H. Laman & C. Boshoff: RNA interference: a potential tool against Kaposi's sarcoma-associated herpesvirus. Curr Opin Infect Dis 16, 593-600 (2003)